Streetbeat News

Earnings

NI

NiSource reported Q3 2024 adjusted earnings per share of $0.20, surpassing the analyst consensus estimate of $0.16 by 25%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:35 am

WRK

Smurfit Westrock anticipates a combined adjusted EBITDA of approximately $4.7 billion for the full year 2024.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:35 am

ZBH

Zimmer Biomet has revised its financial guidance for FY24, lowering its adjusted EPS forecast to $7.95-$8.05 from $8.00-$8.15 and reducing its revenue growth projection to 3.5%-4% from 4%-5%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:33 am

HUM

Humana has updated its 2024 earnings guidance, projecting a GAAP EPS of at least $12.89, slightly above prior guidance but below the $13.36 estimate. The adjusted EPS is expected to be at least $16, aligning with prior guidance but slightly below the $16.17 estimate.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:33 am

SW

Smurfit WestRock reported Q3 sales of $7.67 billion, missing the analyst consensus estimate of $8.20 billion by 6.45%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:33 am

CAT

Caterpillar shares are experiencing a decline due to disappointing Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:33 am

CVEO

Civeo reported its Q3 2024 financial results, with a GAAP EPS of $(0.36), missing the estimate by $(0.02). However, the company exceeded sales expectations with $176.3 million, beating the estimate of $168.755 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:33 am

HUM

Humana reported a Q3 adjusted benefits expense ratio of 89.8%, up from 86.4% a year ago, indicating increased costs relative to revenue.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:32 am

TECH

Bio-Techne reported its Q1 2025 financial results, with adjusted EPS of $0.42 beating the estimate of $0.38, and sales of $289.458 million surpassing the expected $280.260 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:32 am

CAT

Caterpillar's Q3 2024 earnings and sales missed analyst estimates, with EPS at $5.17 versus the expected $5.36 and sales at $16.106 billion versus the expected $16.284 billion. This represents a 4.19% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:31 am